𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin

✍ Scribed by Norio Akuta; Fumitaka Suzuki; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Yoshiyuki Suzuki; Tetsuya Hosaka; Masahiro Kobayashi; Mariko Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Hiromitsu Kumada


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
143 KB
Volume
82
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Substitution of amino acid (aa) 70 and 91 in the core region of hepatitis C virus (HCV) genotype 1b can predict the response to pegylated interferon (PEG‐IFN)/ribavirin combination therapy, but its impact on triple therapy of telaprevir/PEG‐IFN/ribavirin is not clear. The aims of this study were to investigate the rate of HCV RNA loss following 12‐week triple therapy, and determine the effect of aa substitutions on very early (within 48 hr) viral dynamics. Sixty‐seven patients infected with HCV genotype 1b (HCV‐1b) and high viral load who received 12‐week triple therapy were studied. RNA loss could be achieved in 2%, 34%, 80%, 92%, 95%, 94%, and 90% of the patients after 1, 2, 4, 6, 8, 10, and 12 weeks of triple therapy, respectively. After 24‐hr treatment, the proportion of patients with Arg70 and Leu91 substitutions with ≥3.0 log fall in HCV RNA was significantly higher than those with <3.0 log fall (P = 0.008). However, the aa substitution patterns in the core region did not influence the fall in HCV RNA after 48‐hr treatment. Multivariate analysis identified substitutions of aa 70 and 91 (P = 0.014) and level of viremia at baseline (≥7.0 log IU/ml; P = 0.085) as independent parameters that determined the ≥3.0 log fall in HCV RNA level after 24‐hr triple therapy. It is concluded that 12‐week triple therapy achieved high rates of loss of HCV RNA in Japanese patients infected with HCV‐1b and high viral load, and that the aa substitution pattern in the core region seems to influence very early viral dynamics. J. Med. Virol. 82:575–582, 2010. © 2010 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Amino acid substitution in hepatitis C v
✍ Norio Akuta; Fumitaka Suzuki; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 2 views

Genetic variation near the IL28B gene and substitution of amino acid (aa) 70 and 91 in the core region of hepatitis C virus (HCV) genotype 1b can predict the response to pegylated interferon (PEG-IFN)/ribavirin combination therapy, but its impact on triple therapy of telaprevir/PEG-IFN/ribavirin is

Pretreatment virus load and multiple ami
✍ K Chayama; A Tsubota; M Kobayashi; K Okamoto; M Hashimoto; Y Miyano; H Koike; M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 3 views

biochemical and histological improvement. 3,4 Several factors Hepatitis C virus (HCV) genotype 1b and high precan predict a poor response to interferon therapy, e.g., high treatment virus load are predictive factors of poor repretreatment virus load, genotype 1b, advanced histological sponse to inte

Amino acid substitutions in the hepatiti
✍ Norio Akuta; Fumitaka Suzuki; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract Previous studies provided a direct experimental evidence for the contribution of HCV core protein in the development of insulin resistance (IR), but the clinical impact of HCV core region on IR is still not clear. The present study evaluated the impact of Amino acid (aa) substitutions o